BERTIGO Tablet
Betahistine Dihydrochloride
16 mg
ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE
| Pack size | 30's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 0.95 AED |
Available as:
Indications
BERTIGO Tablet is used for:
Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.
Adult Dose
Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.
Child Dose
Renal Dose
Administration
Should be taken with food.
Contra Indications
Phaeochromocytoma. Porphyria.
Precautions
Active peptic ulcer, bronchial asthma, pregnancy and lactation.
Pregnancy-Lactation
Interactions
May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.
Adverse Effects
Side effects of Betahistine Dihydrochloride :
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.
Mechanism of Action
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
Note
BERTIGO 16 mg Tablet manufactured by ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE. Its generic name is Betahistine Dihydrochloride. BERTIGO is availble in Saudi Arabia.
Farmaco SA drug index information on BERTIGO Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.